IDO1 Expression Increased After Neoadjuvant Therapy Predicts Poor Pathologic Response and Prognosis in Esophageal Squamous Cell Carcinoma

Indoleamine 2,3-dioxygenase (IDO1) plays an important role in tumor immune evasion. In this study, we investigated the changes of tumor IDO1 expression and CD8+ tumor-infiltrating lymphocytes (TILs) status in tumor microenvironment (TME) after neoadjuvant chemoradiotherapy (NCRT) or neoadjuvant chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiao, Ruidi, Zheng, Xiaoli, Sun, Yanan, Feng, Zhuo, Song, Shuai, Ge, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358399/
https://www.ncbi.nlm.nih.gov/pubmed/32733806
http://dx.doi.org/10.3389/fonc.2020.01099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358399/
https://www.ncbi.nlm.nih.gov/pubmed/32733806
http://dx.doi.org/10.3389/fonc.2020.01099

Ejemplares similares